Oxford Biomedica plc (LON:OXB)
623.00
+2.00 (0.32%)
Apr 16, 2026, 8:53 AM GMT
Oxford Biomedica Revenue
In the year 2025, Oxford Biomedica had annual revenue of 168.74M GBP with 31.01% growth. Oxford Biomedica had revenue of 95.52M in the half year ending December 31, 2025, with 105.51% growth.
Revenue
168.74M
Revenue Growth
+31.01%
P/S Ratio
4.45
Revenue / Employee
172.71K
Employees
977
Market Cap
750.79M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 168.74M | 39.94M | 31.01% |
| Dec 31, 2024 | 128.80M | 39.26M | 43.84% |
| Dec 31, 2023 | 89.54M | -50.45M | -36.04% |
| Dec 31, 2022 | 139.99M | -2.81M | -1.97% |
| Dec 31, 2021 | 142.80M | 55.07M | 62.77% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Genus | 672.00M |
| Oxford Nanopore Technologies | 223.90M |
| hVIVO | 54.47M |
| Bioventix | 12.54M |
| Scancell Holdings | 4.71M |
| PureTech Health | 4.66M |
| 4basebio | 1.78M |
| Ondine Biomedical | 1.18M |
Oxford Biomedica News
- 20 days ago - Oxford BioMedica PLC (OXBDF) Full Year 2025 Earnings Call Highlights: Strong Revenue Growth and ... - GuruFocus
- 20 days ago - Full Year 2025 Oxford Biomedica PLC Earnings Call Transcript - GuruFocus
- 20 days ago - Oxford Biomedica (OXBDF) Reports Strong Revenue Growth for FY - GuruFocus
- 21 days ago - Oxford BioMedica PLC (LSE:OXB) Q4 2025 Earnings Report Preview: What To Expect - GuruFocus
- 23 days ago - Bristol Myers (BMY) Partnership Enhances Oxford Biomedica's Outlook - GuruFocus
- 7 weeks ago - EQT backs out of takeover bid for UK's Oxford Biomedica - Reuters
- 3 months ago - UK's Oxford Biomedica confirms unsolicited bid from funds managed by EQT - Reuters
- 9 months ago - UK's Oxford Biomedica maintains annual outlook - Reuters